Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series

• Главные авторы: Yan Hu (Автор), Siying Ren (Автор), Lulu Yang (Автор), Zhongyi Tong (Автор), Ruoyao Wang (Автор), Wei Han (Автор), Chao Zeng (Автор), Jina Li (Автор), Peng Xiao (Автор), Li Wang (Автор), Fenglei Yu (Автор), Wenliang Liu (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: Evidence of osimertinib as neoadjuvant therapy for resectable non-small cell lung cancer (NSCLC) are currently lacking. This case series study aimed to assess the safety and feasibility of neoadjuvant osimertinib therapy followed by surgery for resectable NSCLC.Materials and methods: Pat...